Vect-Horus Strengthens Board of Directors with Appointment of Jean-Christophe Dantonel as New Member

We’re pleased to welcome Jean-Christophe Dantonel as a new member of the Vect-Horus Board of Directors!

Dr. Dantonel brings over two decades of profound expertise in biological sciences, project management, and clinical research to his new role.

“He brings key skills to our company at an important stage of its development, with a combination of clinical research and business experience which will be invaluable as we innovate to develop vectors that facilitate targeting and delivery of therapeutic and imaging agents to enhance their efficacy,” says Alexandre Tokay, co-founder and CEO of Vect-Horus

Click here for the full press release